Status:
COMPLETED
Lymph Node Ratio and Kras Mutation in R Colon Cancer
Lead Sponsor:
Mansoura University
Conditions:
Colon Cancer Stage III
Eligibility:
All Genders
16-70 years
Phase:
PHASE3
Brief Summary
clinical impact of LN ratio with Kras expression in colon cancer
Detailed Description
LNR and K ras were evaluated with correlated with different clinicopathological parameters of the patients, PFS and OS.
Eligibility Criteria
Inclusion
- Stage III colon cancer
Exclusion
- Stage I, II, IV
Key Trial Info
Start Date :
March 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 26 2019
Estimated Enrollment :
433 Patients enrolled
Trial Details
Trial ID
NCT04342676
Start Date
March 10 2017
End Date
August 26 2019
Last Update
April 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Oncology Center
Al Mansurah, Dakahlia Governorate, Egypt, 35516